Synedica Tirzepatide 40mg
Synedica Tirzepatide 40mg is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist synthesized for scientific evaluation. Supplied as a stable lyophilized powder, it provides high reproducibility for in vitro assay setups and receptor kinetic research.
Technical Specifications & Compound Overview
| Parameter | Specification |
| Product Name | Synedica Tirzepatide |
| Quantity | 40mg |
| Appearance | Lyophilized white cake/powder |
| Purity Level | $\ge 98\%$ verified via HPLC & MS |
| Recommended Storage | $-20^\circ\text{C}$ dry storage |
| Usage | Scientific Research & Analytical Testing Only |
Key Benefits of Using Synedica Tirzepatide 40mg in Laboratory Settings
Dual Agonist Mechanism Studies
By co-activating GIP and GLP-1 receptors, Tirzepatide enables researchers to explore synergistic signaling pathways unavailable in single-receptor ligands.
Batch Consistency & Quality Control
Every batch of Synedica Tirzepatide 40mg undergoes Mass Spectrometry (MS) and High-Performance Liquid Chromatography (HPLC) testing. Certificates of Analysis are available upon request for institutional documentation.
Handling, Reconstitution, and Safety Protocols
-
Reconstitution: Use sterile, laboratory-grade solvent suitable for peptide research.
-
Handling: Wear appropriate protective gear including gloves and eye protection.
-
Storage: Keep lyophilized vials cold and dry. Store reconstituted solutions at $2^\circ\text{C}-8^\circ\text{C}$ for short-term evaluation or $-80^\circ\text{C}$ for extended periods.
Related Research Materials
-
Explore our triple-receptor compound: Synedica Retatrutide 40mg.
-
Learn more about our lab standards on the Synedica Homepage.